- CCAAT/enhancer-binding
protein alpha is a
protein encoded by the
CEBPA gene in humans. CCAAT/enhancer-binding
protein alpha is a
transcription factor...
-
neoplasms with
germline predisposition Acute myeloid leukaemia with
germline CEBPA mutation Myeloid neoplasms with
germline DDX41
mutation Myeloid neoplasms...
-
study for
their prognostic impact in AML. However, only FLT3-ITD, NPM1,
CEBPA and c-KIT are
currently included in
validated international risk stratification...
-
Regulators repressing hexokinase III
expression in AML
include PML-RARA and
CEBPA.
Regarding acute lymphoblastic leukemia (ALL),
functional enrichment analysis...
-
mutations have been
implicated in
cancer (e.g.,
mutations in
genes p53, ATM,
CEBPA, and PPARgamma).
Marfan syndrome is
caused by
mutations in the FBN1 gene...
- Meshinchi, S (25 June 2009). "Prevalence and
prognostic implications of
CEBPA mutations in
pediatric acute myeloid leukemia (AML): a
report from the Children's...
- Q7Z692 2729 CEACAM20 HGNC:24879 Q6UY09 2730 CEACAM21 HGNC:28834 Q3KPI0 2731
CEBPA HGNC:1833 P49715 2732
CEBPB HGNC:1834 P17676 2733
CEBPD HGNC:1835 P49716...
- I
trial of the first-ever
saRNA drug MTL-
CEBPA in
patients with
liver cancer, in an
attempt to
activate CEBPA gene. Li LC,
Okino ST, Zhao H,
Pookot D,...
- of the
master regulators PPARĪ³ and CCAAT/enhancer-binding
protein alpha (
CEBPA). This
paves the way for
possible genetic obesity treatments.
Another class...
-
found in 10% of cases.
Mutations in
transcription factors such as RUNX1,
CEBPA, NPM1 and WT1 have been
found in up to 30% of cases.
Mutations of CBL are...
